AUS
NZ
UK
CA
USA
IND
Healthcare
Advances in Biopharma: Kidney Imaging, Therapies, and Diagnostics
December 30, 2024 06:13 PM AEDT| By Team Kalkine MediaHighlights,Telix Pharmaceuticals (TLX) is advancing its kidney cancer imaging agent for potential US approval.,Dimerix (DXB) achieves a milestone in recruiting for its phase III kidney disease trial.,Proteomics International (PIQ) develops a highly a...
Imricor Medical Expands into Middle East with First Sales in Qatar, Shares Rise 8.55%
December 30, 2024 01:38 PM AEDT| By Team Kalkine MediaHighlights:,Imricor has secured its first purchase order for MRI-guided ablation equipment in Qatar.,The company is working with exclusive distributor East Agency WWL to introduce its iCMR labs to leading cardiac centres in Qatar.,Imricor’s share pri...
Proteomics International Shares Surge Nearly 20% on Monday. Here's Why.
December 30, 2024 01:23 PM AEDT| By Team Kalkine MediaHighlights,Proteomics International Laboratories unveils PromarkerEndo blood test, capable of diagnosing all stages of endometriosis with high accuracy.,The test’s breakthrough results, published in,Human Reproduction,, could revolutionize diagnosis,...
Goodman Group Surges Over 45% in 2024, Fueled by AI-Driven Data Centre Demand
December 30, 2024 11:43 AM AEDT| By Team Kalkine MediaHighlights,Goodman Group's stock rises over 45% in 2024, its best performance since 2006.,Data centres now make up 42% of Goodman’s AU$12.8 billion development pipeline.,Australia's data-centre market sees booming investment, led by global hyperscale...
Pro Medicus Scores Fourth Major Contract in a Month, Shares Edge Higher
December 30, 2024 11:37 AM AEDT| By Team Kalkine MediaHighlights,Pro Medicus secures a $15 million, five-year contract with Duke University Health System.,This marks the company’s fourth significant deal in just over a month, building on prior multi-million dollar agreements.,The deal expands Pro Medicu...
Pro Medicus (ASX:PME) Expands North American Reach with Duke University Deal
December 30, 2024 12:00 AM AEDT| By Team Kalkine MediaHighlights,- Pro Medicus (PME) secures a $15 million deal with Duke University Health System.,- The agreement extends Pro Medicus’ cloud-based imaging services through Visage 7 Open Archive.,- The Visage 7 Viewer contract has been extended to 2029.,P...
ASX Small Caps to Watch: Undervalued Stocks With Insider Confidence in December 2024
December 27, 2024 12:00 AM AEDT| By Team Kalkine MediaHighlights:,Resilient Market Amid Challenges,: The ASX 200 showed a modest gain of 0.29% in December 2024, despite lingering inflation concerns. Small-cap stocks have gained attention for their growth potential, especially those exhibiting insider ac...
AVITA Medical Secures FDA Approval for RECELL GO® Mini, Expanding Treatment Options for Smaller Wounds
December 24, 2024 11:25 AM AEDT| By Team Kalkine MediaHighlights:,FDA Approval:,RECELL GO Mini, designed for smaller wounds, enhances the functionality of the RECELL GO platform.,Optimized Design:,The cartridge minimizes resource use and waste, broadening accessibility for clinicians.,Market Growth:,Tar...
Imugene Secures Major Capital Boost to Advance Clinical Trials
December 24, 2024 12:00 AM AEDT| By Team Kalkine MediaHighlights,- Imugene extends cash runway to late 2025 through strategic capital injection.,- Funding supports clinical trials for key programs, including azer-cel and VAXINIA.,- Additional cost-saving measures strengthen financial position.,Imugene (...
Avita Medical's Spray-On Skin Device Earns FDA Approval
December 24, 2024 12:00 AM AEDT| By Team Kalkine MediaHighlights,- Avita Medical (AVH) receives FDA approval for RECELL GO Mini, expanding its advanced wound care solutions.,- The new Mini GO device targets smaller wounds, enhancing resource efficiency and flexibility for clinicians.,- Avita plans to in...
Polynovo's Record Sales Drive ASX Momentum Amid Market Recovery
December 23, 2024 02:55 PM AEDT| By Team Kalkine MediaHighlights:,Polynovo,(PNV) surged on record-breaking monthly sales.,ASX recovered from last week’s technical disruptions to open on time.,Real Estate, Financials, and Consumer Discretionary sectors lead ASX gains.,The Australian Securities Exchange (...
PolyNovo Achieves Record $10.1M Monthly Sales in November 2024
December 23, 2024 01:12 PM AEDT| By Team Kalkine MediaHighlights,Record Monthly Sales:,PolyNovo reported,$10.1M,in unaudited sales for November 2024, marking the company's highest monthly performance to date.,Geographic Expansion:,United States:,November sales reached,$7.0M,, contributing to year-to-dat...
Rhythm Biosciences Acquires Genetype Business from Genetic Technologies
December 23, 2024 12:34 PM AEDT| By Team Kalkine MediaHighlights,Strategic Acquisition:,Rhythm Biosciences has entered into an Asset Sale Agreement (ASA) with the administrators of Genetic Technologies Ltd (GTG) to acquire the Genetype business, a leader in genetic risk assessment for cancers.,Transacti...
Prescient Therapeutics Shares Surge 24% on FDA Approval for PTX-100 Phase 2 Trial
December 23, 2024 11:41 AM AEDT| By Team Kalkine MediaHighlights,FDA Clears Phase 2 IND:,The U.S. FDA has approved Prescient Therapeutics' Investigational New Drug (IND) application for its Ras pathway inhibitor, PTX-100, targeting advanced cutaneous T-cell lymphomas (r/r CTCL).,Strong Phase 1b Results:...
Pro Medicus Shares Rise Following AU$30 Million Contract with Duly Health and Care
December 23, 2024 10:59 AM AEDT| By Team Kalkine MediaHighlights,AU$30 Million Contract Signed:,Pro Medicus secures a seven-year deal with Duly Health and Care, the largest physician-directed medical group in the U.S. Midwest.,Cloud-Based Imaging Platform Rollout:,The deal includes implementing Pro Medi...
FDA Clears Prescient Therapeutics (ASX:PTX) for Phase 2 PTX-100 Trial Targeting T-Cell Lymphomas
December 23, 2024 12:00 AM AEDT| By Team Kalkine MediaHighlights,Prescient Therapeutics (PTX) receives FDA clearance for a Phase 2 trial of PTX-100.,The trial focuses on relapsed and refractory cutaneous T-cell lymphomas (r/r CTCL).,Phase 1b data showed promising safety and response rates for PTX-100.,P...
Pro Medicus Expands U.S. Presence with $30m Deal
December 23, 2024 12:00 AM AEDT| By Team Kalkine MediaHighlights,Pro Medicus (PME) secures a long-term partnership with Duly Health and Care.,The $30m agreement focuses on implementing advanced cloud imaging solutions.,The new system replaces legacy technologies across DHC's expansive operations.,Pro Me...
Integral Diagnostics Completes Merger with Capitol Health, Appoints New Directors, and Refinances Debt
December 20, 2024 02:28 PM AEDT| By Team Kalkine MediaHighlights,Merger Completion:,Integral Diagnostics (ASX: IDX) has completed its merger with Capitol Health (ASX: CAJ) through a scheme of arrangement.,Scheme Consideration:,Capitol shareholders received 0.12849 Integral shares for each Capitol share...
Little Green Pharma to Acquire Health House Australia for AU$1.25Mn
December 20, 2024 02:14 PM AEDT| By Team Kalkine MediaHighlights,Strategic Acquisition:,Little Green Pharma signs a binding letter of intent to acquire Health House Australia Pty Ltd for $1.25 million.,Revenue Boost:,Health House, a cashflow breakeven business, generates $7.5 million in annual revenue.,...
Radiopharm Theranostics Advances with Phase 1 Cancer Trial Approval
December 20, 2024 01:51 PM AEDT| By Team Kalkine MediaHighlights,Radiopharm,Theranostics,(RAD) secures ethics approval for a Phase 1 cancer trial,.,The trial targets HER2-positive cancers using the novel 177Lu-RAD202 therapy,.,Lutetium-177 isotope aims to deliver localized radiation with minimal side ef...
Advertise your brand on Kalkine Media